Intrahepatic cholangiocarcinoma: Prognostic factors for recurrence and survival in a series of 67 patients treated surgically at a single center

Cir Esp (Engl Ed). 2021 Aug-Sep;99(7):506-513. doi: 10.1016/j.cireng.2021.06.015. Epub 2021 Jul 4.

Abstract

Introduction: Intrahepatic cholangiocarcinoma is a primary liver neoplasm whose only curative treatment is surgery. The objective of this study was to determine the prognostic factors for survival of intrahepatic cholangiocarcinoma treated surgically with curative intent.

Methods: Sixty-seven patients who had been treated surgically for this neoplasm were collected at Bellvitge University Hospital between 1996 and 2017. Epidemiological, clinical, surgical, anatomopathological, morbidity, mortality and survival data have been analysed.

Results: Postoperative study reflects our centre's experience in the surgical treatment of intrahepatic cholangiocarcinoma over a period of 21 years. Lymphadenectomy was associated with increased morbidity, and vascular invasion in the pathological study was the most important risk factor in the survival analysis.

Conclusions: This study reflects our centre's experience in the surgical treatment of intrahepatic cholangiocarcinoma over a period of 21 years. Lymphadenectomy was associated with increased morbidity, and vascular invasion in the pathological study was the most important risk factor in the survival analysis.

Keywords: Colangiocarcinoma intrahepático; Factores pronósticos; Hepatectomy; Hepatectomía; Intrahepatic cholangiocarcinoma; Prognostic factors; Supervivencia; Survival.

MeSH terms

  • Bile Duct Neoplasms* / surgery
  • Cholangiocarcinoma* / surgery
  • Hepatectomy
  • Humans
  • Liver Neoplasms*
  • Prognosis
  • Retrospective Studies
  • Treatment Outcome